Walleye Trading’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Walleye Trading’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-438	Closed	-$26K	–	5632
2018 Q3	$26K	Buy	+438	New	+$22.3K	﹤0.01%	4775
2016 Q2	–	Sell	-600	Closed	-$21K	–	5891
2016 Q1	$21K	Buy	+600	New	+$22K	﹤0.01%	4420

Other funds holding BSTC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Walleye Trading's BSTC Position: Q4 2018 in Review

Walleye Trading sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2018, closing a stake of 438 shares — an estimated $26K sold.

Walleye Trading first reported a position in BSTC in Q1 2016 and held it in 2 quarters. The position peaked at $26K in Q3 2018. 107 funds tracked by Wall St. Rank hold BSTC as of Q4 2018.

Walleye Trading reported no remaining BioSpecifics Technologies Corp. position as of Q4 2018 after selling out during the quarter.
Walleye Trading sold 438 BioSpecifics Technologies Corp. shares in Q4 2018, an estimated $26K.
Walleye Trading first reported a position in BioSpecifics Technologies Corp. in Q1 2016 and held it in 2 quarters.
Walleye Trading's BioSpecifics Technologies Corp. position peaked at $26K in Q3 2018.
107 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.